Urology & Nephrology

September 16, 2024/Cancer/Research

New Studies Reinforce Benefits of Combination Treatment for Urothelial Carcinoma

Enfortumab vedotin plus pembrolizumab benefited patients, regardless of biomarker expression

Physician smiles at patient in a preoperative setting

September 12, 2024/Urology & Nephrology/Urology

Improving the Bladder Cancer Survivorship Experience for Women

What updated techniques, counseling and a changing workforce could mean

August 28, 2024/Cancer/Research

Case Study: Patient with Metastatic Urothelial Carcinoma Has No Remaining Evidence of Disease

Treatment involved checkpoint inhibitor, surgery and intravesical therapy

Surgeons in the operating room with the single-port robot

August 20, 2024/Urology & Nephrology/Urology

Novel Single-Port Robotic Urology Surgery Surpasses 1,000 Cases

Applications, outcomes and untapped potential

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

August 15, 2024/Urology & Nephrology/Urology

Counseling Your Patients on SGLT-2 Inhibitors and Adverse Urologic Outcomes

Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes

Illustration of red blood cells in motion

August 5, 2024/Urology & Nephrology/Urology

Review Underscores Impact of Red Blood Cell Disorders on Male Reproduction

Early, individualized diagnosis and comprehensive management key to preserving fertility

Clinician holding urine sample in gloved hand

July 31, 2024/Urology & Nephrology/Nephrology

Severe Hyponatremia: Are You Monitoring The Urine Output?

Key considerations when diagnosing and managing severe hyponatremia

Man in clinical setting speaking with doctor

July 10, 2024/Urology & Nephrology

Medical Management of Benign Prostatic Hyperplasia

Medical management remains the starting point for most symptomatic patients seeking treatment